v3.26.3
Strategic Agreements - Additional Information (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Current portion of derivative liabilities - royalty agreement   $ 2,600   $ 2,600    
Long-term portion of derivative liabilities - royalty agreement   1,369   1,369   $ 2,041
Ligand Development Funding Agreement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Payments totalling to fund development $ 15,000          
Maximum payments to receive upon achievement of milestones $ 8,000          
Agreement royalty term period from first sale 15 years          
Agreement termination notice period 90 days          
Aggregate potential future milestone payments remaining under arrangement   5,000   5,000    
Derivative liabilities   3,900   3,900    
Current portion of derivative liabilities - royalty agreement   2,600   2,600    
Long-term portion of derivative liabilities - royalty agreement   1,400   1,400   2,000
Long-term liability   24,900   $ 24,900   $ 17,800
Effective interest rate percentage of potential future royalty payments       50.20%   44.90%
Non-cash interest expense   $ 2,800 $ 1,500 $ 7,200 $ 4,100  
Ligand Development Funding Agreement [Member] | Maximum            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Royalty percentage 9.80%          
Ligand Development Funding Agreement [Member] | Minimum            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Royalty percentage 8.00%